Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid-phase synthesis of deglycobleomycin and bleomycin.

Christopher J Leitheiser1, Sidney M Hecht

  • 1University of Minnesota, Department of Chemistry, 207 Pleasant Street SE, Minneapolis, MN 55455, USA.

Current Opinion in Drug Discovery & Development
|February 5, 2004
PubMed
Summary

Solid-phase synthesis enables the creation of numerous deglycobleomycin and bleomycin analogs. This breakthrough facilitates a deeper understanding of these complex anticancer glycopeptide antibiotics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alteration of CD40 Protein Expression by Tyrosine Phosphorylation of the NF-κB p50 Subunit.

Chembiochem : a European journal of chemical biology·2025
Same author

Functionalized Nitrobenzothiadiazoles as Embedded Fluorescent Probes.

The Journal of organic chemistry·2025
Same author

Biological Regulation Studied <i>in Vitro</i> and <i>in Cellulo</i> with Modified Proteins.

Accounts of chemical research·2025
Same author

Enhancement of <i>N</i>-Methyl Amino Acid Incorporation into Proteins and Peptides Using Modified Bacterial Ribosomes and Elongation Factor P.

ACS chemical biology·2024
Same author

Opportunities and challenges for innovative and equitable healthcare.

Nature reviews. Drug discovery·2024
Same author

Elongation Factor P Modulates the Incorporation of Structurally Diverse Noncanonical Amino Acids into <i>Escherichia coli</i> Dihydrofolate Reductase.

Journal of the American Chemical Society·2023

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Pharmacology

Background:

  • Bleomycins are glycopeptide antibiotics used in cancer treatment.
  • Their complex structure has historically limited analog synthesis.
  • Understanding bleomycin's biochemical properties requires diverse analogs.

Purpose of the Study:

  • To describe a solid-phase synthesis method for bleomycin analogs.
  • To enable the creation of fully functional and active deglycobleomycin and bleomycin analogs.
  • To overcome limitations in synthesizing bleomycin derivatives.

Main Methods:

  • Solid-phase synthesis methodology.
  • Synthesis of deglycobleomycin analogs.
  • Synthesis of bleomycin analogs.

Related Experiment Videos

Main Results:

  • Successfully synthesized over 160 unique deglycobleomycin and bleomycin analogs.
  • Developed a scalable and efficient solid-phase approach.
  • Produced fully functional and active bleomycin analogs.

Conclusions:

  • Solid-phase synthesis is a powerful tool for generating diverse bleomycin analogs.
  • This methodology significantly advances research into bleomycin's biochemical properties and potential applications.
  • Facilitates the exploration of novel anticancer agents based on the bleomycin scaffold.